BAK1 and hematologic disorder: Accordingly, we analyzed the ability of the cell-permeable Bak BH3 peptide (PETK) to induce chemosensitivity, particularly to cisplatin (CDDP), a drug used as alternative treatment in cases of refractory hematologic malignancies [45, 46].